EC2 Software NMIS BioDose vulnerabilities
5 known vulnerabilities in EC2 Software NMIS BioDose from Mirion Medical. 5 are rated high or critical. Each entry lists the affected versions and the release that fixes it, where the vendor has published one.
Latest first
- 7.8 High severity
EC2 Software NMIS BioDose: Use of Hard-coded Credentials
NMIS/BioDose software V22.02 and previous versions contain executable binaries with plain text hard-coded passwords. These hard-coded passwords could allow unauthorized access to both the application and database.
- 7.8 High severity
EC2 Software NMIS BioDose: Incorrect Permission Assignment for Critical Resource
NMIS/BioDose V22.02 and previous versions' installation directory paths by default have insecure file permissions, which in certain deployment scenarios can enable users on client workstations to modify the program executables and libraries.
- 7.5 High severity
EC2 Software NMIS BioDose: Incorrect Permission Assignment for Critical Resource
NMIS/BioDose V22.02 and previous version installations where the embedded Microsoft SQLServer Express is used are exposed in the Windows share accessed by clients in networked installs. By default, this directory has insecure directory paths that allow access
- 8.8 High severity
EC2 Software NMIS BioDose: Incorrect Permission Assignment for Critical Resource
NMIS/BioDose V22.02 and previous versions rely on a Microsoft SQL Server database. The SQL user account 'nmdbuser' and other created accounts by default have the sysadmin role. This can lead to remote code execution through the use of certain built-in stored p
- 8.8 High severity
EC2 Software NMIS BioDose: Use of Client-Side Authentication
NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connect